Form D · Biotechnology
ImmuVen, Inc.
Champaign, IL · CIK 0001468696
Offering snapshot reported Aug 15, 2011 · SEC filing
- Reported sold
- $250K Indefinite offering
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Jun 22, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 15, 2011 | Initial | $250,000 | No comparison | 5 | SEC filing |
| Sep 13, 2010 | Amendment | $255,000 | $50,000vs Jul 22, 2009 | 4 | SEC filing |
| Jul 22, 2009 | Initial | $205,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 04
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-164446
Source: Form D, filed Aug 15, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Timothy Charles Hoerr | Executive |
| David M Kranz | Director, Executive, Promoter |
| Cheryl Lee Quinn | Executive |
| Patrick M Schlievert | Director, Executive, Promoter |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
60 Hazelwood Drive
Champaign, IL, 61820
Champaign, IL, 61820